1. Home
  2. BATRK vs FOLD Comparison

BATRK vs FOLD Comparison

Compare BATRK & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BATRK
  • FOLD
  • Stock Information
  • Founded
  • BATRK 1991
  • FOLD 2002
  • Country
  • BATRK United States
  • FOLD United States
  • Employees
  • BATRK N/A
  • FOLD N/A
  • Industry
  • BATRK Broadcasting
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • BATRK Industrials
  • FOLD Health Care
  • Exchange
  • BATRK Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • BATRK 2.5B
  • FOLD 2.5B
  • IPO Year
  • BATRK N/A
  • FOLD 2007
  • Fundamental
  • Price
  • BATRK $38.60
  • FOLD $9.49
  • Analyst Decision
  • BATRK Strong Buy
  • FOLD Buy
  • Analyst Count
  • BATRK 3
  • FOLD 7
  • Target Price
  • BATRK $58.00
  • FOLD $30.29
  • AVG Volume (30 Days)
  • BATRK 338.6K
  • FOLD 5.0M
  • Earning Date
  • BATRK 11-05-2025
  • FOLD 11-04-2025
  • Dividend Yield
  • BATRK N/A
  • FOLD N/A
  • EPS Growth
  • BATRK N/A
  • FOLD N/A
  • EPS
  • BATRK N/A
  • FOLD N/A
  • Revenue
  • BATRK $723,307,000.00
  • FOLD $598,704,000.00
  • Revenue This Year
  • BATRK $14.16
  • FOLD $21.12
  • Revenue Next Year
  • BATRK $3.97
  • FOLD $21.23
  • P/E Ratio
  • BATRK N/A
  • FOLD N/A
  • Revenue Growth
  • BATRK 6.62
  • FOLD 21.28
  • 52 Week Low
  • BATRK $35.46
  • FOLD $5.51
  • 52 Week High
  • BATRK $47.18
  • FOLD $10.43
  • Technical
  • Relative Strength Index (RSI)
  • BATRK 36.61
  • FOLD 67.88
  • Support Level
  • BATRK $38.29
  • FOLD $8.69
  • Resistance Level
  • BATRK $39.64
  • FOLD $9.64
  • Average True Range (ATR)
  • BATRK 1.02
  • FOLD 0.38
  • MACD
  • BATRK -0.06
  • FOLD 0.03
  • Stochastic Oscillator
  • BATRK 16.08
  • FOLD 85.29

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: